Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$38.6M Buy
300,014
+15,007
+5% +$1.76M 0.84% 21
2026
Q1
$34.3M Sell
285,007
-4,713
-2% -$544K 0.95% 16
2025
Q4
$30.5M Buy
289,720
+25,344
+10% +$2.38M 0.77% 22
2025
Q3
$22.2M Buy
264,376
+19,823
+8% +$1.63M 0.58% 23
2025
Q2
$19.4M Buy
244,553
+10,101
+4% +$803K 0.57% 24
2025
Q1
$20.3M Sell
234,452
-39,001
-14% -$3.64M 0.67% 22
2024
Q4
$27.2M Buy
+273,453
New +$28.2M 0.81% 16

Other funds holding MRK

Avanza Fonder's MRK Position: Q2 2026 in Review

Avanza Fonder increased its Merck (MRK) stake by 5.3% in Q2 2026, buying an estimated $1.76M and bringing the position to 300,014 shares worth $38.6M. The position accounts for 0.84% of the portfolio, ranked #21.

Avanza Fonder first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 1,509 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Avanza Fonder held 300,014 shares of Merck worth $38.6M as of Q2 2026.
  • Avanza Fonder bought 15,007 Merck shares in Q2 2026, an estimated $1.76M.
  • Merck made up 0.84% of Avanza Fonder's portfolio in Q2 2026, its #21 holding.
  • Avanza Fonder first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 1,509 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Avanza Fonder's 13F filing for Q2 2026, filed 17 Jul 2026.